UCLA Seminar on Pharmaceutical Economics and Policy
The UCLA Seminar on Pharmaceutical Economics and Policy was established in the fall of 1990, and continued annually through the spring of 2020. It was suspended due to the pandemic for the academic year 2020-2021, but will resume in the fall of 2021.
Through its first thirty years, the Seminar presented the research and views of a wide range of scholars, policy-makers and industry officials, all with expertise on various facets of the pharmaceutical marketplace. The Seminar has never been limited to academics presenting their pharmaceutical sector related research findings, although these sessions are frequent, but has always reached out to include a larger set of perspectives. The latter have included past and present officials at the Food and Drug Administration, representatives of the investor community and pharmaceutical and insurance industry executives. While focused on the structure and performance of the US industry, it has also included speakers from Europe and Asia which have provided an international flavor. Topics presented include drug pricing, R&D productivity, regulatory policy, and many more. Attached as examples are the schedules for both 2018-2019 and 2019-2020 academic years along with the schedules for its first two years: 1990-1991 and 1991-1992.
The Seminar has long been open to the UCLA and USC communities along with interested members of the public. Current UCLA graduate students are encouraged to enroll in the Seminar, officially listed as HLT POL M204ABC (4 credit units). However, non-enrolled students from UCLA, USC, and other institutions are fully welcome to attend sessions of the Seminar.
To be added to the listserv, interested parties should contact Dr. Z. John Lu at email@example.com.
Telephone: (310) 825-1070
Fax: (310) 825-3317
The schedules for previous seminars are below: